Treatment of Urinary Tract Infections in the Elderly

Diagnosis Considerations

Elderly patients often present with atypical UTI symptoms such as confusion, functional decline, fatigue, or falls rather than classic dysuria, according to the European Urology guidelines 1, 3
Asymptomatic bacteriuria is common in elderly patients (up to 40% in institutionalized women) and should NOT be treated with antibiotics, as recommended by the European Urology guidelines 3
Negative results for nitrite and leukocyte esterase on dipsticks suggest absence of UTI, but specificity is only 20-70% in the elderly, as reported in European Urology 1, 4

The European Urology guidelines recommend fosfomycin 3g as a single dose, nitrofurantoin, pivmecillinam, trimethoprim-sulfamethoxazole, or fluoroquinolones, with treatment duration of 7-10 days for uncomplicated cystitis 1, 2
Nitrofurantoin (if no renal impairment) is recommended by the European Urology guidelines 1

Calculate creatinine clearance to determine appropriate dosing, as recommended by the Praxis Medical Insights guidelines 4
Adjust antibiotic doses based on renal function to prevent toxicity, according to the Praxis Medical Insights guidelines 4
Avoid nitrofurantoin in patients with creatinine clearance <30 mL/min, as recommended by the Praxis Medical Insights guidelines 4

For recurrent UTIs in elderly women, consider fosfomycin 3g every 10 days as prophylaxis, as recommended by the Praxis Medical Insights guidelines 2
Trimethoprim-sulfamethoxazole (40/200mg) three times weekly (with dose adjustment in renal impairment) may be used for prophylaxis, according to the Praxis Medical Insights guidelines 2

Treating asymptomatic bacteriuria, which is common but does not require antibiotics, as recommended by the Praxis Medical Insights guidelines 2
Failing to adjust antibiotic doses based on renal function, as warned by the Praxis Medical Insights guidelines 2, 4
Using fluoroquinolones as first-line therapy due to their side effect profile and risk of resistance, as cautioned by the Praxis Medical Insights guidelines 4
Neglecting to monitor for adverse effects, which may present atypically in elderly patients, as recommended by the Praxis Medical Insights guidelines 2